Aldeyra The (ALDX) vs ImageneBio Inc (IMA)
A side-by-side comparison of Aldeyra The and ImageneBio Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALDX
Aldeyra The
$0.88HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
IMA
ImageneBio Inc
$4.76HealthcareDelayed quote: Oct 6, 2026, 1:40 PM EDT
Total return — ALDX vs IMA
growth of $100 · dividends reinvested · last 6yALDX -91.9% (-34.2%/yr)IMA -98.8% (-52.0%/yr)ALDX compounded faster over this window
Log scale — wide-divergence pair
ALDX IMA
ALDX vs IMA: by the numbers
- •IMA is the larger company ($54M vs $53M market cap).
- •Both run net losses; ALDX's is the smaller (0.00% vs -5668.62% net margin).
Metrics side by side
Valuation
| Metric | ALDX | IMA |
|---|---|---|
| P/B ratio | 1.40 | 0.38 |
Profitability
| Metric | ALDX | IMA |
|---|---|---|
| Gross margin | 0.00% | -29.12% |
| Operating margin | 0.00% | -6056.37% |
| Net margin | 0.00% | -5668.62% |
| ROE | -60.85% | -36.94% |
| ROIC | -63.52% | -40.53% |
Growth (annualized)
| Metric | ALDX | IMA |
|---|---|---|
| Total return CAGR (5Y) | -36.54% | -50.73% |
Frequently asked
- How have ALDX and IMA total returns compared?
- Over the past 5 years, ALDX delivered -36.54% and IMA delivered -50.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.